Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate(CAS: 92501-87-6)

Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate (CAS: 92501-87-6) falls under the GHS classification for health and environmental hazards. It is subject to REACH regulations in the European Union, requiring suppliers to register the substance with the European Chemicals Agency. In the US, FDA and EPA may also have specific requirements concerning its handling and use in pharmaceuticals and environmental releases.

Alternatives to Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate (CAS: 92501-87-6) include other esters and amides with similar functional groups. Isomers such as 4-[2-(4-morpholinyl)ethoxy]benzoic acid may be used as precursors. Common alternative reagents like morpholine and other alcohol derivatives can be explored for similar synthetic purposes.

The market trend for Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate (CAS: 92501-87-6) shows increasing interest in its use as a pharmaceutical intermediate. Research is focusing on its potential applications in drug development, particularly in treatments for cardiovascular and neurological disorders. Price trends are stable, with a growing focus on sustainable and eco-friendly synthesis methods.

Waste containing Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate (CAS: 92501-87-6) should be collected in sealed containers and disposed of through professional waste disposal services. Incineration is a common method for disposal, ensuring proper destruction of the substance. Environmental protection measures include monitoring and minimizing the release of contaminants into the environment, adhering to local and international regulations for hazardous waste management.